Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gossamer Bio Inc
(NQ:
GOSS
)
0.6680
-0.0020 (-0.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gossamer Bio Inc
< Previous
1
2
3
4
5
Next >
Analyst Ratings for Gossamer Bio
July 14, 2022
Over the past 3 months, 5 analysts have published their opinion on Gossamer Bio (NASDAQ:GOSS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
July 14, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
Where Gossamer Bio Stands With Analysts
April 26, 2022
Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:
Via
Benzinga
Gossamer Bio Pulls Plug On Mid-Stage Ulcerative Colitis Program
April 25, 2022
Via
Benzinga
Recap: Gossamer Bio Q4 Earnings
March 03, 2022
Gossamer Bio (NASDAQ:GOSS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Gossamer Bio Earnings Preview
March 02, 2022
Gossamer Bio (NASDAQ:GOSS) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 13, 2022
Via
Benzinga
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
July 13, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program
July 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 13, 2022
Via
Benzinga
Gossamer Bio Announces $120 Million Private Placement Financing
July 13, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Publication of Key Preclinical Data in the European Respiratory Journal Highlighting Seralutinib’s Potential for the Treatment of PAH
June 09, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update
May 10, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
71 Biggest Movers From Yesterday
April 27, 2022
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 25, 2022
Via
Benzinga
Gossamer Bio Announces GB004 Topline Results from Phase 2 SHIFT-UC Study in Ulcerative Colitis and Provides Corporate Update
April 25, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022
April 18, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 06, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
April 06, 2022
Upgrades
Via
Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...
Via
Benzinga
Gossamer Bio to Announce Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 3, 2022
February 28, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 08, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021
November 02, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Addition of Two CNS-Penetrant BTK Inhibitors to its Product Candidate Pipeline: GB5121 & GB7208
October 11, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021
October 07, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
September 27, 2021
Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume...
Via
Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (...
Via
Benzinga
31 Stocks Moving In Monday's Mid-Day Session
September 27, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to...
Via
Benzinga
50 Biggest Movers From Yesterday
September 28, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 50% to close at $3.60 on Monday after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from...
Via
Benzinga
Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role
September 21, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.